Mechanism of intestinal transport of an organic cation, tributylmethylammonium in Caco-2 cell monolayers

被引:0
作者
Soon-Sun Hong
Sang-Cherl Moon
Chang-Koo Shim
机构
[1] Seoul National University,Research Institute of Pharmaceutical Science
[2] Seoul National University,Department of Pharmaceutics, College of Pharmacy
来源
Archives of Pharmacal Research | 2006年 / 29卷
关键词
Quaternary ammoniums; TBuMA; Caco-2; P-gp;
D O I
暂无
中图分类号
学科分类号
摘要
Many quaternary ammonium salts are incompletely absorbed after their oral administration and may also be actively secreted into the intestine. However, the underlying mechanism(s) that control the transport of these cations across the intestinal epithelium is not well understood. In this study, the mechanism of absorption of quaternary ammonium salts was investigated using Caco-2 cell monolayers, a human colon carcinoma cell line. Tributylmethyl-ammonium (TBuMA) was used as a model quaternary ammonium salts. When TBuMA was administrated at a dose of 13.3 imole/kg via iv and oral routes, the AUC values were 783.7±43.6 and 249.1±28.0 μmole·min/L for iv and oral administration, indicating a lower oral bioavailability of TBuMA (35.6%). The apparent permeability across Caco-2 monolayers from the basal to the apical side was 1.3 times (p<0.05) greater than that from the apical to the basal side, indicating a net secretion of TBuMA in the intestine. This secretion appeared to be responsible for the low oral bioavailability of the compound, probably mediated by p-gp (p-glycoprotein) located in the apical membrane. In addition, the uptake of TBuMA by the apical membrane showed a Na+ dependency. Thus, TBuMA appears to absorbed via a Na+ dependent carrier and is then secreted via p-gp related carriers.
引用
收藏
相关论文
共 50 条
  • [41] Effects of metformin on bile salt transport by monolayers of human intestinal Caco-2 cells
    Carter, D
    Howlett, HCS
    Wiernsperger, NF
    Bailey, C
    DIABETES OBESITY & METABOLISM, 2002, 4 (06) : 424 - 427
  • [42] In vitro Characterization of the Intestinal Absorption Mechanism of Dihydromyricetin in Caco-2 Cell Model
    Liu, Lu
    Sun, Sen
    Li, Xiaohua
    LATIN AMERICAN JOURNAL OF PHARMACY, 2018, 37 (05): : 908 - 913
  • [43] Evaluation of intestinal dioxin permeability using human Caco-2 cell monolayers
    Natsume, Y
    Satsu, H
    Hatsugai, Y
    Watanabe, H
    Sato, R
    Ashida, H
    Tukey, RH
    Shimizu, M
    FOOD SCIENCE AND TECHNOLOGY RESEARCH, 2003, 9 (04) : 364 - 366
  • [44] Transport of Val-Leu-Pro-Val-Pro in human intestinal epithelial (Caco-2) cell monolayers
    Lei, Lin
    Sun, Haiyan
    Liu, Dong
    Liu, Liegang
    Li, Shimin
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2008, 56 (10) : 3582 - 3586
  • [45] Gamma-aminobutyric acid (GABA) transport across human intestinal epithelial (Caco-2) cell monolayers
    Thwaites, DT
    Basterfield, L
    McCleave, PMJ
    Carter, SM
    Simmons, NL
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (03) : 457 - 464
  • [46] Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers
    Satake, M
    Enjoh, M
    Nakamura, Y
    Takano, T
    Kawamura, Y
    Arai, S
    Shimizu, M
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2002, 66 (02) : 378 - 384
  • [47] Transport of Pregabalin in Rat Intestine and Caco-2 Monolayers
    Nancy Jezyk
    Cheng Li
    Barbra H. Stewart
    Xiaochun Wu
    Howard N. Bockbrader
    David Fleisher
    Pharmaceutical Research, 1999, 16 : 519 - 526
  • [48] Transport of pregabalin in rat intestine and Caco-2 monolayers
    Jezyk, N
    Li, C
    Stewart, BH
    Wu, XC
    Bockbrader, HN
    Fleisher, D
    PHARMACEUTICAL RESEARCH, 1999, 16 (04) : 519 - 526
  • [49] Characterization of the transport of the organic cation [3H]MPP+ in human intestinal epithelial (Caco-2) cells
    Martel, F
    Calhau, C
    Azevedo, I
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 361 (05) : 505 - 513
  • [50] Transport Characteristics of Candesartan in Human Intestinal Caco-2 Cell Line
    Zhou, Lingjie
    Chen, Xiaoping
    Gu, Yuanqing
    Liang, Jianying
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2009, 30 (05) : 259 - 264